comparemela.com

Latest Breaking News On - Rakovina therapeutics inc - Page 7 : comparemela.com

Rakovina Therapeutics Inc Announces Closing of $1 5 Million Convertible Debenture Financing

Rakovina Therapeutics Inc Announces Closing of $1 5 Million Convertible Debenture Financing
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

British columbiaUnited kingdomUnited statesCompany commonRakovina therapeutics incHealth canadaDrug administrationRakovina therapeutics inc david hymanchief financial officeremailVenture exchangeRegulation services providerCompany theCompany the debenture unitsCompanya warrant shareDebenture unitWarrant shareCommon shares

Rakovina Therapeutics Inc Announces Closing of $1 5

VANCOUVER, British Columbia, May 29, 2023 (GLOBE NEWSWIRE) Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) is pleased to.

United statesBritish columbiaUnited kingdomCompany the debenture unitsRakovina therapeutics incDrug administrationRegulation services providerCompany commonCompany theCompanya warrant shareVenture exchangeHealth canadaDebenture unitWarrant shareCommon sharesClosing date

Small cap snapshot: Soma Gold, Thor Explorations, Revolve Renewable Power, PyroGenesis, Numinus

Small cap snapshot: Soma Gold, Thor Explorations, Revolve Renewable Power, PyroGenesis, Numinus
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesRobertj foxSteve hansonRobert kaulLithium incRakovina therapeutics incInternational conventionMetals corpRogers creek property to cascade copper corpImmunic incKillum wynn creative incMaxim groupConsortium of multiple sclerosis centersLiam greenlawWynn creative

Rakovina Therapeutics Inc Announces 2022 Financial Results

VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company.

Comunidad autonoma de catalunaUnited kingdomBritish columbiaUnited statesDavid hymanJeffrey bachaDrug administrationHealth canadaProactive investors nort america incRegulation services providerNational brain tumor societyAmerican association of cancer researchResearch developmentNational research council of canadaVenture exchangeRakovina therapeutics inc

Rakovina reveals new data about lead candidate s tumor-fighting properties

Rakovina Therapeutics Inc (TSX-V:RKV) revealed new data indicating that its kt-3000 lead candidate could be effective in treating certain tumors resistant.

United statesAmerican association of cancer researchRakovina therapeutics incAmerican associationCancer researchMads daugaard

vimarsana © 2020. All Rights Reserved.